|
NT5C2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62636570877339E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.25599539049881E-11 |
| Normal-vs-Stage2 |
3.49809999855566E-08 |
| Normal-vs-Stage3 |
8.41549052665869E-14 |
| Normal-vs-Stage4 |
4.35895763928329E-12 |
| Stage1-vs-Stage2 |
7.626600E-01 |
| Stage1-vs-Stage3 |
2.676200E-02 |
| Stage1-vs-Stage4 |
9.055000E-03 |
| Stage2-vs-Stage3 |
1.631830E-01 |
| Stage2-vs-Stage4 |
3.255600E-02 |
| Stage3-vs-Stage4 |
3.480000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
6.440500E-04 |
| Normal-vs-Asian |
1.5061999999455E-06 |
| Caucasian-vs-AfricanAmerican |
9.690300E-02 |
| Caucasian-vs-Asian |
6.789800E-02 |
| AfricanAmerican-vs-Asian |
7.887800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.19879661752975E-11 |
| Normal-vs-Female |
1.63757896132211E-12 |
| Male-vs-Female |
8.797800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.02079997180249E-09 |
| Normal-vs-Age(41-60Yrs) |
8.41549052665869E-14 |
| Normal-vs-Age(61-80Yrs) |
1.8774981569436E-12 |
| Normal-vs-Age(81-100Yrs) |
3.950100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.097600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.676100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.475600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.396200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.198000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.015000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.92880000030138E-07 |
| Classical-VS-Follicular |
1.276830E-01 |
| Classical-VS-Other |
2.876400E-01 |
| Classical-VS-Normal |
1.64812608005604E-12 |
| Tall-VS-Follicular |
2.2754999995378E-07 |
| Tall-VS-Other |
2.570400E-02 |
| Tall-VS-Normal |
1.62592161956354E-12 |
| Follicular-VS-Other |
7.090000E-01 |
| Follicular-VS-Normal |
3.11009999998113E-06 |
| Other-VS-Normal |
7.363700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.80319981168964E-10 |
| Normal-vs-N1 |
3.88730048150876E-10 |
| N0-vs-N1 |
8.100200E-02 |
|
|
